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Abstract: 
 
Objective: To estimate the return on investment (ROI) of a workplace initiative to reduce work–
family conflict in a group-randomized 18-month field experiment in an information technology 
firm in the United States. 
 
Methods: Intervention resources were micro-costed; benefits included medical costs, 
productivity (presenteeism), and turnover. Regression models were used to estimate the ROI, and 
cluster-robust bootstrap was used to calculate its confidence interval. 
 
Results: For each participant, model-adjusted costs of the intervention were $690 and company 
savings were $1850 (2011 prices). The ROI was 1.68 (95% confidence interval, −8.85 to 9.47) 
and was robust in sensitivity analyses. 
 
Conclusion: The positive ROI indicates that employers’ investment in an intervention to reduce 
work–family conflict can enhance their business. Although this was the first study to present a 
confidence interval for the ROI, results are comparable with the literature. 
 
Keywords: Work-family conflict | workplace intervention | workplace flexibility | supervisor 
support | return on investment | financial outcomes | prevention research 
 
Article:  
 
Work–family conflict (WFC) occurs when workers struggle to manage both their work and 
personal obligations.1–3 Work–family conflict has been linked to lower family, marital, life, and 
job satisfaction 4; to higher work stress, turnover intentions,5 and absenteeism 4; and to lower 
organizational commitment and productivity.3,4,6–9 As a result, work–family initiatives 
intended to support employees’ lives outside of work and reduce WFC have been implemented 
increasingly in US workplaces.10,11 Nevertheless, the effects of these initiatives on WFC are 
not well known as most were either not developed on empirically based principles and/or not 
systematically evaluated. Moreover, few studies have utilized scientifically rigorous designs, 
such as longitudinal data collection or randomization into intervention and comparison groups, to 
test the effects of workplace policies and practices on WFC and its correlates.8 
 
To address this scientific gap, the National Institutes of Health and the Centers for Disease 
Control and Prevention established the Work, Family, and Health Network (“network”) in 
2005.12 The goal of the network is to advance the field of workplace psychosocial interventions 
by targeting WFC to improve the health and well-being of workers and their families. The 
network designed an intervention targeting three elements: (1) enhancing employees’ control 
over their work time, (2) increasing supervisor support for employees to manage work and 
family responsibilities, and (3) reorienting the culture toward results instead of time spent in 
meetings or at the office. The network assessed the efficacy of this intervention via a group 
randomized field experiment in the information technology division of a large Fortune 500 
company (referred to as “Tomo”) in the United States.13,14 
 
Previous research suggests that positive changes in employee stress, including reduced WFC, 
may benefit employers financially.8 Improved health and well-being may affect health care costs 
directly; furthermore, there is a significant amount of evidence linking health risks (eg, stress) to 
indirect business costs in the form of absenteeism, workers’ compensation costs, and decreased 
work performance (presenteeism).15–19 Strong associations exist between employee health and 
work performance.18,20,21 Furthermore, some uncontrolled studies have shown positive 
associations between improvement in health status and work performance.22,23 The most 
common measures of workplace health-related productivity include absenteeism, presenteeism, 
and employee turnover/replacement.24 
 
Accurate estimates of the economic return of workplace initiatives to reduce WFC are critical to 
establishing such initiatives as strategic expenditures. A useful way for communicating the 
financial ramifications of a given initiative is the return on investment (ROI), a metric often used 
in business administration that compares an initiative's costs to its financial benefits.25 No study 
to date has estimated the ROI to the workplace of implementing an initiative to reduce WFC. 
This article estimates the ROI of the network intervention, named STAR (support, transform, 
achieve, results), as implemented in Tomo. Previous workplace ROI studies focus mainly on 
wellness programs for weight loss and fitness, and few of them used scientifically rigorous 
designs.4,26–28 To our knowledge, no study in the workplace literature has assessed the 
statistical significance of the ROI estimates they present. In this study, the cost of STAR is 
compared with the aggregate change in the following three organizational costs: presenteeism, 
voluntary termination of employment, and health care utilization. This study relies on the group-
randomized design of the underlying network field experiment 13 to establish whether investing 
in STAR is worthwhile from a company perspective, and is the first study to calculate confidence 
intervals for ROI estimates. 
 
1 METHODS 
1.1 Intervention 
 
STAR encompassed three components designed to support and build on each other: participatory 
training sessions, computer-based training (CBT), and behavioral self-monitoring.14 Face-to-
face participatory sessions were delivered to employees and managers by external consultants. 
Overall, six sessions were delivered over a 4-month period, four for managers and employees 
together (to learn intervention concepts that focus on results and not location and timing of 
work)29,30 and two for managers only (to reinforce intervention support and cultural changes). 
Participatory sessions were linked with two outside activities for all employees to strengthen 
learning by self-monitoring as they put the new concepts into practice. Managers participated in 
one CBT session designed to increase family-supportive behaviors that are known to affect 
outcomes, such as employee health, absenteeism, turnover, and job satisfaction.31 Examples of 
family-supportive behaviors include helping an employee find a replacement if absent, asking 
how employees are doing, communicating genuine concern about employees’ work/life 
challenges, and showing that managers value involvement in nonwork life.14 Computer-based 
training was designed in software built on behavioral principles of instructional design 32 and 
assessed understanding using pre- and posttests and intermittent quizzes. Transfer of CBT 
knowledge to worksites was supported with behavioral self-monitoring designed by the research 
team to help managers set goals and increase support for their employees.33,34 Managers 
completed two 2-week behavioral self-monitoring trials using iPod Touch devices to observe and 
record supportive behaviors.35 The trials involved goal setting, daily self-monitoring and 
tracking of family and performance supportive behaviors, and individual and group feedback. 
Intervention materials are available for download at 
http://www.workfamilyhealthnetwork.org 
. Methods, measures, and study design are described in more detail in Bray et al.13 
 
1.2 Design 
 
Our ROI analysis builds on the group-randomized multisite controlled experimental study of 
STAR in Tomo. Researchers aggregated existing “workgroups” (teams of employees and 
supervisors) to create study groups to serve as the unit of randomization. There were 56 study 
groups, with some comprising large teams of workers reporting to the same supervisor, whereas 
others included multiple teams reporting to the same senior leader or working closely together on 
the same project. Adaptive randomization ensured balance on job function, leadership, and size 
of the study group. For details on study design, see Bray et al 13 and Kelly et al.36 
 
Study groups were randomized to intervention or control/usual practice. In the intervention arm, 
a multicomponent process to reduce WFC was delivered as described above. Primary evaluation 
data for this study were collected using computer-assisted personal interviews (CAPIs) lasting 
about 60 minutes with employees and their supervisors (“employees”) in the intervention and 
control groups at baseline, 6, 12, and 18 months. Corporate administrative data were available to 
the research team on an ongoing basis. Data collectors were blind to the experimental condition 
of the participants, who consented to each component of data collection. 
 
The ROI is calculated as the ratio of the difference between the benefits, defined as changes in 
organizational costs that result from the intervention, and costs of the intervention to the costs of 
the intervention [ROI = (Benefits - Costs)/Costs]. The primary variables used to calculate the 
ROI were differences between the intervention and control groups in (1) intervention costs, (2) 
productivity represented by presenteeism (ie, being present at work but working at a reduced 
capacity), (3) health care utilization, and (4) voluntary termination (“turnover”). 
 
1.3 Sample 
 
A total of 1427 employees were eligible to participate in STAR and the workplace data 
collection using CAPI. To be eligible for CAPI survey data collection, employees had to be 
located in the two cities where data collection occurred and had to be classified as employees, 
rather than independent contractors, of the company. Of those eligible, 73.1% completed the 
baseline survey (n = 1044), and of these 94.5% (n = 987) completed any of the follow-up 
surveys. Employees with only baseline data (n = 57) were excluded from the analysis. 
 
The ROI was conducted on the sample of respondents who completed both baseline and at least 
one follow-up surveys with the following exclusions. Seventeen employees who were 
randomized to the intervention condition but never invited to participate in any STAR sessions 
because of an error on the part of the research staff were excluded. In addition, eight employees 
who because of restructuring began reporting to a supervisor already going through STAR, were 
excluded because they were not randomized to either arm. Fourteen employees were excluded 
because they were missing data required to calculate intervention benefits. Finally, two 
employees who were lacking demographic information were excluded. The resulting analytic 
sample consists of 946 employees (473 STAR and 473 in control condition). Figure 1 confirms 
that response rates are similar for employees in intervention and control conditions and that all 
study groups identified as eligible for the study were randomized and had at least some 
employees who participated in the survey. 
 
2 MEASURES 
 
FIGURE 1. Study design, sample formation, and response rates. 
 
2.1 Intervention Costs 
 
Intervention costs were estimated using a micro-costing approach (ie, data were collected on the 
exact number and type of each resource consumed). Costs were measured from the perspective 
of the implementing organization and excluded research-related costs. 
 
Activities required to implement STAR in Tomo were separated into the following: 
customization (ie, adapting STAR to the context of the organization's existing policies and 
regulations, eg, Tomo documents review and tailoring of computer training material); start-up 
(ie, activities required to begin the intervention, eg, scheduling participatory face-to-face training 
sessions); and implementation (ie, activities performed as part of delivering the intervention, eg, 
employees participation in training sessions). Costs were separated into labor (eg, time spent by 
company staff in intervention-related activities) and nonlabor (eg, contracted services, materials, 
and space related to the intervention). For customization and start-up activities, the study used 
semi-structured interviews to assess staff time spent on each activity; for implementation 
activities, individual-level attendance for all employees and managers were captured in 
intervention rosters and matched with records on the time spent on each session. Data were 
gathered on space and materials associated with each activity. See Barbosa et al 37 for complete 
cost study details. 
 
2.2 Intervention Benefits 
 
Intervention benefits related to lowering WFC included reductions in self-reported presenteeism, 
reductions in employee medical care costs, and lower turnover. The three benefits are consistent 
with the study of Nicholson et al,38 which assumes that a workplace health improvement 
program provides four potential benefits to employers: better productivity (reflected in lower 
presenteeism), lower medical expenditures, lower turnover, and fewer absences. This study did 
not collect data on workdays missed because of a health condition to measure absenteeism. 
Nevertheless, we deal with this issue in the sensitivity analysis by valuing unused paid time off 
(PTO), as explained below. 
 
The baseline, 6-, 12- and 18-month postbaseline CAPI surveys collected self-reported measures 
of workplace outcomes, physical and mental health outcomes, demographic information, and 
family relationships. Specific measures relevant to the ROI included presenteeism, health care 
utilization, sex, age, and education. Corporate administrative data were collected on subjects who 
consented to administrative data collection on an ongoing basis and were merged with CAPI 
survey data. Administrative data provided information on voluntary termination. 
 
The CAPI survey included the presenteeism questions of the World Health Organization's Heath 
and Work Performance Questionnaire (HPQ).20,39 To measure presenteeism, the HPQ 10-point 
self-rating scale was used, with 10 representing the best work performance and zero representing 
the worse job performance anyone could have. We took an approach used in previous studies in 
which the self-rating represented the proportion of work time that the employee was optimally 
engaged in his or her job; employees were assumed to be working at 50% capacity for the 
remaining time.19,40–43 The self-rating, which represented the past 4 weeks, was scaled to the 
6-month CAPI data collection period. Ideally, we would have had access to administrative data 
on job performance, instead of relying on a self-reported measure of productivity. Nevertheless, 
scores on global questions about the ability to perform one's job have been shown to be 
significantly correlated with business performance scores.39 A review of health-related 
productivity measurement instruments rated the HPQ very high as a performance indicator, 
particularly for presenteeism.24 The instrument has excellent reliability, validity, sensitivity to 
change, and high external validity.20,44 
Intervention benefits related to health care utilization used survey questions about the frequency 
of health care utilization (hospital nights, emergency department or urgent care visits, and other 
outpatient visits) over the previous 6 months and whether health care use was related to 
substance use or mental health. Self-reported health care use is prone to recall bias,45 and ideally 
we would have had access to claims data. Nevertheless, health care utilization questions were 
taken from the Economic Form 90,46 which has shown sensitivity to changes in health care use. 
Because we did not have an estimate of the number of employees covered by Tomo's health 
insurance plan, we used the estimate of a census report that shows that 76.8% individuals with 
management and professional roles participate in their employers’ health insurance.47 
 
3 ANALYSIS 
3.1 Dollar Valuation of Intervention Costs and Benefits 
 
Intervention resource use was valued in monetary terms by multiplying the quantity of resources 
by their unit cost. Staff time spent on STAR activities was valued with employees’ compensation 
defined as salary costs, available in administrative data, loaded with Tomo's fringe rate of 30%. 
Space was valued using the average yearly lease rate, and other nonlabor resources were valued 
at their market price.37 
 
Presenteeism and voluntary termination were monetized using employees’ compensation. 
Presenteeism costs were assumed to be half the employee's hourly compensation for every hour 
in which the employee was working at 50% capacity. Voluntary termination costs were assumed 
to be 1.5 times the employee's total annual compensation, on the basis of Ramall,48 who 
estimates the cost of voluntary termination for companies to be “a minimum of one year's pay 
and benefits, or a maximum of two years’ pay and benefits (p. 52).” Other studies have also 
shown that in most instances the firm's cost of missed work or productivity loss exceeded the 
wage rate by a “multiplier” greater than one, depending on the ease of finding an appropriate 
replacement worker.49,50 Termination costs were applied to the next CAPI interview that would 
have occurred had the employee not left Tomo. 
 
Employee health care utilization was valued using unit costs from the literature. Costs of 
emergency department episodes ($869 in 2011 dollars), outpatient visits ($155), and days spent 
in the hospital ($1746) were taken from French and Martin.51 Costs of outpatient visits, 
specifically related to alcohol, drug use, or mental health ($178), were taken from Roebuck and 
colleagues’ estimate of the cost of outpatient substance abuse treatment.52 Total health care 
costs were calculated as the sum of all health care utilization costs for that wave. 
 
3.2 ROI Estimation 
 
We applied a 3% annual discount rate to costs and benefits accrued in the study's second year to 
account for the changing value of a dollar over time and the fact that costs and benefits occurring 
immediately are valued more highly than those occurring in the future.53,54 Intervention 
benefits at 6, 12, and 18 months after intake were summed, yielding a single postintervention 
measure of benefit for each employee. To calculate the ROI, separate regressions of intervention 
costs and benefits were estimated. Some individuals assigned to the control condition 
participated in the intervention, usually because of a postrandomization reassignment to another 
workgroup within the company; however, they were classified as part of the control group 
because we conducted an intention-to-treat analysis. Thus, it was necessary to model intervention 
costs rather than using the average of the treatment group. Intervention costs were regressed on 
the treatment indicator, sex, age, race, an indicator of college completion, and a set of 
randomization covariates. Randomization covariates included indicators of the function of the 
study group, the number of employees in the study group, and the vice president to which the 
study group reports.13 Intervention benefits were regressed on the same covariates, as well as a 
baseline measure of organizational costs, the number of data collection waves missed not due to 
voluntary termination, and calendar quarter indicators. Intervention costs were estimated using 
ordinary least squares regression. Intervention benefits were estimated using marginal effects 
from Gamma GLM regression with a log-link to account for the strong positive skew in the data, 
which was not present in the intervention costs.55 Both models were estimated with cluster-
robust standard errors with the study groups specified as the unit of clustering. 
 
The ROI was calculated as the difference between the intervention effects on organizational 
benefits and intervention costs, divided by the effect on intervention costs, where intervention 
effects were represented by the marginal effects on the treatment indicator in the models 
described above. The confidence interval around the ROI was estimated by sampling clusters 
(study groups) with replacement and assigning a new cluster identifier to each cluster selected. 
The main regression models were estimated for each bootstrap replicate, resulting in an estimate 
of the ROI for each replicate. The 95% confidence interval was the 2.5 and 97.5 percentiles of 
the distribution of ROI estimates.56 
 
3.3 Sensitivity Analyses 
 
We analyzed the impact of assumptions and uncertainty in key parameters on the estimated ROI 
through a series of five sensitivity analyses: 
 
1. As a proxy to absenteeism, we included hours of PTO taken as an additional intervention 
benefit. We did not have a true measure of absenteeism because our survey did not include the 
HPQ questions on workdays missed because of health reasons. The measure of PTO reported in 
administrative data included both sick and personal days. Paid time off used was valued with 
employees’ compensation. There were 253 employees (27%), with missing data on PTO for one 
or more observations. We imputed missing values using regression-based conditional mean 
imputation. Variables were regressed on age, sex, and job title. To incorporate uncertainty, 
missing values were imputed as the predicted value plus a random draw from the model implied 
error distribution.57 
2. We added bonuses gained to employees’ total compensation. Bonuses were not part of 
employees’ compensation in the main analysis because there were 108 employees (11%), with 
missing data on bonuses for one or more observations. Values were imputed using the same 
approach as above. 
3. We included the 14 employees with missing data on variables required to calculate 
intervention benefits. Values were imputed using the same approach as above. 
4. We applied a discount rate of 0% and 6%. 
5. We adjusted the valuation of intervention benefits upward or downward, one at a time. 
Presenteeism costs were varied by changing the cost of work time for which self-reported 
productivity was not optimal by 20%; health care costs were adjusted by varying the unit costs 
applied by 20%; and turnover costs were varied by changing the wage rate multiplier by 33%. 
 
All analyses were conducted using Stata 13 (StataCorp, College Station, TX). All costs are 
presented in 2011 US dollars. 
 
4 RESULTS 
 
 
 
TABLE 1 Descriptive Statistics at Baseline 
 
Table 1 presents the baseline characteristics of the analytic sample for the control and STAR 
intervention groups. The typical subject is a white, male, college graduate between 45 and 46 
years old. The imbalance between groups on sociodemographic characteristics supports 
covariate-adjusted ROI estimation. Approximately 20% of the subjects managed other 
employees. 
 
 
 
TABLE 2 Unadjusted Means of Intervention Costs and Benefits by Treatment Groupa 
 
Table 2 presents unadjusted average intervention costs and benefits by group. The average cost 
of the intervention was $707 among employees randomly assigned to the intervention. Because 
some employees shifted between workgroups after treatment assignment, the average 
intervention cost among the control group was $15. In the 6 months before the intervention, the 
firm incurred an average of nearly $6000 per employee in presenteeism and health care. Costs 
incurred by the firm on the three organizational outcomes averaged $29,952 for the control group 
and $25,326 for the STAR group in the 18 months after the baseline interviews. Differences 
between pre- and postintervention costs within each group are explained by the omission of 
turnover costs in the preintervention period and the difference in the periods covered (6 months 
vs 18 months). The values in Table 2 do not account for some subjects leaving the study before 
the end of the data collection period. 
 
In the preintervention period, presenteeism costs were considerably higher than health care 
utilization costs. Control subjects had higher presenteeism costs and lower health care utilization 
costs, but none of the differences were statistically significant. 
 
Similar to the preintervention period, in the postintervention period, control subjects had higher 
presenteeism costs and lower health care utilization costs. Control subjects had considerably 
higher postintervention voluntary termination costs (approximately $4200 higher). Nevertheless, 
because voluntary termination was a rare event 5 with a high cost, the standard deviation was 
quite high and the difference was not statistically significant. 
 
 
 
TABLE 3 Multivariate Models of Intervention Costs and Benefitsa 
 
Table 3 presents marginal effects from the regressions of intervention costs and benefits. Model-
adjusted average intervention benefits in the postintervention period were $28,497 for the control 
and $26,647 for the treatment group. Adjusted average intervention costs were $16 and $706, 
respectively. Differences in these values, which are equal to the marginal effects on the treatment 
indicators, yield an estimated ROI of 1.68 (95% confidence interval, -8.85 to 9.47). 
 
 
 
TABLE 4 Sensitivity Analysesa 
 
Table 4 presents the results of the sensitivity analyses. Including PTO taken as a benefit along 
with presenteeism, health care utilization, and turnover decreased the ROI to 1.24. Including the 
employee bonuses in the total compensation figure raised the average hourly compensation from 
$57 to $63 and increased the ROI to 2.00. Reintroducing 14 subjects with estimated benefits 
calculated using imputed values also increased the ROI to 2.02. Removing or doubling the 
discount rate had a minimal impact on the ROI, increasing or decreasing the estimate by 0.06, 
respectively. 
 
The organizational outcome with the highest impact on the ROI was voluntary termination. 
When voluntary termination costs were increased to two times total annual compensation, the 
ROI increased to 2.70. When they were decreased to 1 time total annual compensation, the ROI 
decreased to 0.76. Changing presenteeism or health care utilization costs by 20% in either 
direction had a very small impact on the ROI estimate. 
 
5 DISCUSSION 
 
This article presented the ROI of a multicomponent intervention delivered in a group-
randomized, 18-month, field experiment designed to reduce employees’ WFC and improve the 
health and well-being of workers and their families. The main analysis accounted for differences 
between trial arms in intervention costs and three benefits: presenteeism, voluntary termination, 
and health care utilization. Consistent with economic theory, the first two organizational 
outcomes were monetized using employees’ wage.58 To increase the accuracy of employers’ 
“value,” we also included the cost of fringe benefits and bonuses (in sensitivity analysis) as a 
measure of total compensation. To test the sensitivity of our results to model assumptions and 
address the uncertainty in some parameters, we conducted several sensitivity analyses. We 
estimated the 95% confidence interval of the ROI, accounting for the cluster-randomized design 
of the study. 
 
After adjusting for baseline differences, the intervention led to company savings of $1850 per 
participant, over an 18-month period. The overall ROI was 1.68 (95% confidence interval, -8.85 
to 9.47), indicating that on average organizational costs fell by $1.68 for every $1.00 spent on 
STAR. We found that the intervention benefit with the highest impact on the ROI was voluntary 
termination followed by presenteeism and health care utilization. Voluntary termination has the 
highest monetary valuation and, despite being a rare event, the impact on the overall ROI is 
substantial. Including PTO taken as a proxy to absenteeism resulted in a lower ROI. This might 
be explained by a higher number of personal days, not sick days, taken by the intervention group. 
Nevertheless, the data did not support disentangling the two. Our main analysis adopted a 
conservative approach whereby we excluded individuals with missing values in intervention 
benefits and did not include bonus in employees’ total compensation. Relaxing each of those 
assumptions resulted in a slightly higher estimate of the ROI. 
 
This study advances the field of economic evaluations of workplace interventions, in general, by 
presenting the confidence interval around the ROI estimated in the context of a clustered 
experimental study and, in particular, by providing the first estimate of the ROI of a workplace 
intervention to reduce WFC. Systematic reviews of the financial return of worksite health 
promotion programs show that few, if any, studies conduct sensitivity analyses or report the 
confidence intervals of their financial return estimates.4,59 
 
Although no previous study reports the ROI of initiatives to reduce WFC, our results can be put 
into the context of previous ROI studies of other health-related interventions implemented in the 
workplace. As previously noted,37 most studies analyzing the ROI of a workplace intervention 
have not estimated the cost of the intervention with the rigor that this study does. The adjusted 
cost of STAR was $690 per participant, which is about four times more than the median costs of 
workplace interventions described in the literature, and may explain the lower ROI we found.4 
The reason for this is twofold. First, our analysis of intervention costs included costs beyond 
implementation costs, such as start-up, customization, space, and employee time,37 which have 
not been taken into account in previous studies. Second, STAR was more resource intensive than 
other workplace interventions. A recent meta-analysis of the literature on costs and savings 
associated with employer-based wellness promotion policies found that the majority of the 
programs focused on weight loss and fitness. These programs entailed a combination of self-help 
education materials, individual counseling with health care professionals, or on-site group 
activities led by trained personnel.28 Such interventions do not typically require the extensive 
employee and resource involvement that STAR did. 
 
Despite the differences in the programs analyzed and methods applied, our ROI estimate is 
within the range of ROI estimates of workplace interventions in the literature. Baicker et al,28 
focusing only on health care costs and absenteeism, reported separate ROIs of 3.27 for health 
care costs and 2.73 for absenteeism. van Dongen et al 4 conducted a systematic review of 13 
nonrandomized studies (NRSs) and 4 randomized controlled trials (RCTs) on the financial return 
of worksite health promotion programs aimed at improving nutrition and/or increasing physical 
activity. The review reported that the ROI for absenteeism was 3.25 for NRSs and -0.49 for 
RCTs, the ROI for health care was 0.95 for NRSs and -1.12 for RCT, and for both absenteeism 
and health care the ROI was 3.87 for NRSs and -0.92 for RCTs. The authors called for more 
RCTs of workplace interventions and expressed concern that the cost savings and high ROI of 
the NRSs reviewed were likely the result of selection bias. The authors also suggested that longer 
follow-up duration of the NRSs, combined with the potential for gradually accumulating 
benefits, may have contributed to larger ROIs than in the RCTs. In contrast to this study, which 
included three organizational outcomes, the studies reviewed only included absenteeism and/or 
medical benefits, neglecting other types of financial benefits such as reduced presenteeism and 
turnover. In this study, unadjusted health care costs after STAR were slightly higher in the 
intervention group. An increase in health care utilization after STAR might be related to both 
greater schedule control (a primary target of the intervention) that facilitates health care 
appointments and the training message that managers and coworkers support employees’ pursuit 
of their health and their personal goals. This finding is consistent with previous workplace 
studies.4,28 
 
STAR yielded a positive ROI, showing that employer costs of the intervention were more than 
offset by cost savings, a result that was robust in sensitivity analyses. Although this result was 
not statistically significant by common standards, the robustness of the positive ROI estimate to 
a variety of sensitivity analyses increased confidence that STAR yielded a positive ROI. 
Moreover, no other study has presented confidence intervals around an ROI point estimate, so 
we cannot compare the significance of our results to the significance of ROIs previously 
reported, regardless of their magnitude. Despite the statistical insignificance, our ROI estimate is 
economically meaningful by most financial assessment standards. Furthermore, the 
nonsignificant ROI estimate can partly be attributed to the study being powered to assess the 
impact of the intervention on WFC (for which it was significant 36) rather than for 
organizational outcomes. The study was powered to ensure the identification of the effect of the 
intervention on WFC at [alpha] = 0.05, with power of 0.8. For this reason, expecting not just a 
positive but also a significant ROI for STAR may be too high a threshold. 
 
Five main limitations should be pointed out. First, this study may have understated the true ROI 
because health benefits are likely to accumulate gradually and a longer follow-up period might 
have captured a greater extent of intervention benefits as a result of a reduction in WFC. 
Similarly, we may overstate the true costs of STAR by including start-up and customization 
costs. If these costs are greater in the first worksite to implement STAR, which seems likely, 
then we have overstated the costs that would be incurred by worksites alike that implement 
STAR in the future. Second, health care and presenteeism outcomes were self-reported, and unit 
costs were derived from the literature. Two superior sources of health care cost data–-medical 
claims or industry-specific averages–-were unavailable. Third, we relied on self-reported 
productivity data. It is noteworthy, though, that previous longitudinal research has consistently 
shown that the HPQ self-reported productivity measure significantly predicts administrative 
records of work performance.20,39 Fourth, despite the randomized nature of this study, there 
was some imbalance in demographic characteristics (age, race, and education). Although it is 
possible that our sample inclusion criteria created the imbalance, we found no evidence that 
selection criteria differentially affected one condition over another at baseline. In another 
analysis, we found that the intervention reduced voluntary turnover (Moen et al 5), which is 
consistent with our results here, but this would not explain baseline differences across the study 
conditions. Thus, although we used regression models to adjust outcomes for the imbalance, 
some selection bias may be present. Finally, we did not have data on absenteeism, which was 
excluded from the main analysis. We included PTO used as a proxy to absenteeism in the 
sensitivity analysis. 
 
The RCT design of the study attempted to ensure internal validity, not external validity, which 
might hamper the generalizability of our results. Tomo was characterized by a high-salary, 
highly educated workforce, which might be in line with many other information technology 
companies but not the general workforce. The extent to which our results can be translated to 
other industries depends on the similarity of the workplace environment, specific industry 
characteristics, and on whether the same implementation strategy is and can be followed. To 
partly address concerns that findings are not generalizable beyond a single industry or type of 
workforce, future work by the Work, Family, and Health Network will examine the ROI of a 
WFC intervention in a nursing care facility. A salaried professional workforce like Tomo may 
have different underlying health risks and may respond to the intervention differently than a 
predominantly low-wage workforce in a nursing care facility. 
 
This study shows that employers’ investment in an intervention to reduce WFC can enhance their 
business. It provides further evidence to policy makers who are interested in aligning the social 
welfare objective of improving workers’ health and well-being with the need to make the 
business case to employers. This is particularly relevant in the current climate of health care 
reform in the United States where the Affordable Care Act contains provisions that encourage 
employers to adopt health promotion and risk reduction programs. 
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